on 07 Mar 2023
Last Applicant/ Owned by
830 Winter Street
Waltham
MA
02451
Serial Number
88984877 filed on 18th Dec 2019
Registration Number
6997137 registered on 07th Mar 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"THERAPEUTICS"
"THERAPEUTICS" Color is not claimed as a feature of the mark. Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders The mark consists of two concentric three-quarter circles formed with dashes and dots, with the last quarter-circle on the top right formed by single large dots. The word "Immunitas" in laRead More
Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders
30th Sep 2022
30th Sep 2022
No 88984877
No Service/Collective Mark
No 36592.00003
No
No
No
No
No
No
No
No
26.01.03 -
Incomplete circles (more than semi-circles)
26.01.05 -
Circles made of broken or dotted lines
26.01.17 -
Two concentric circles
26.01.21 -
Circles that are totally or partially shaded
26.01.30 -
Four Circles
The mark consists of two concentric three-quarter circles formed with dashes and dots, with the last quarter-circle on the top right formed by single large dots. The word "Immunitas" in large font extends from within the center of the circles and "THERAPEUTICS" in small font is outside of the semi-circles below the letters "munitas".
| Status Date | Action Taken |
|---|---|
| 07th Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
| 07th Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 01st Feb 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 31st Jan 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 04th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 04th Jan 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 03rd Jan 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 03rd Jan 2023 | DIVISIONAL PROCESSING COMPLETE |
| 03rd Jan 2023 | SOU EXTENSION 5 GRANTED |
| 03rd Jan 2023 | STATEMENT OF USE PROCESSING COMPLETE |
